Tesofensine vs Lixisenatide

Head-to-head comparison of Tesofensine (Tesofensine (NS2330)) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyTesofensineLixisenatide
CategoryWeight ManagementWeight Management
Full NameTesofensine (NS2330)Exendin-4-derived GLP-1 receptor agonist
Molecular Weight426.52 g/mol4858 Da
Half-Life~200-300 hours2-4 hours
Amino AcidsSmall molecule44
Typical Dose10-20 mcg daily
RouteSubcutaneous
Purity>98%≥98%
Studies Count35400
Research StatusPhase III Clinical TrialsApproved

Tesofensine Benefits

  • Potent appetite suppression, increased metabolic rate, enhanced thermogenesis, improved mood during dieting, reduces food reward-seeking behavior

Lixisenatide Benefits

  • postprandial glucose control
  • modest weight loss
  • appetite reduction
  • short-acting option

Tesofensine Dosing

Clinical doses: 0.25-1.0 mg orally once daily. Research typically uses 0.5 mg. Extremely long half-life (8-13 days) means steady-state in 7-10 days.

Lixisenatide Dosing

10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day

Tesofensine Side Effects

  • Dry mouth, insomnia, constipation, increased heart rate, elevated blood pressure. Not recommended with uncontrolled hypertension.

Lixisenatide Side Effects

  • nausea
  • vomiting
  • hypoglycemia when combined with insulin

Research Overview

Tesofensine

Phase II trials showed 12.8 kg average weight loss at 1.0 mg dose over 6 months. Simultaneously inhibits reuptake of norepinephrine, dopamine, and serotonin, producing appetite suppression and increased thermogenesis.

Lixisenatide

Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Tesofensine stacks with:

5-Amino-1MQAOD-9604MOTS-c

Lixisenatide stacks with:

basal-insulinmeal-plan
weight-lossappetite-suppressanttriple-reuptake-inhibitorthermogenesisGLP-1RAshort-actingpostprandial-controlweight-loss-adjacent